Medicare Enrolled

Dr. Stephanie Flagg, M.D.

Rheumatology · Bryn Mawr, PA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
825 OLD LANCASTER RD, Bryn Mawr, PA 19010
6105273800
In practice since 2005 (21 years)
NPI: 1780682815 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Flagg from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Flagg? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Flagg

Dr. Stephanie Flagg is a rheumatology specialist in Bryn Mawr, PA, with 21 years of NPI registration. Based on federal Medicare data, Dr. Flagg performed 112,166 Medicare services across 1,206 unique beneficiaries.

Between the years covered by Open Payments, Dr. Flagg received a total of $10,537 from 55 pharmaceutical and/or device companies across 559 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Flagg is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 21 years in practice ▲ Top 13% volume in PA $10,537 industry payments

Medicare Practice Summary

Medicare Utilization ↗
112,166
Medicare services
Top 13% in PA for rheumatology
1,206
Unique beneficiaries
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~5,341 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Certolizumab injection (Cimzia)
An injection of certolizumab pegol administered under the direct supervision of a physician.
48,400 $4 $10
Golimumab infusion (Simponi Aria)
Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery.
25,350 $11 $35
Abatacept infusion (Orencia)
An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered.
15,800 $34 $65
Denosumab injection (Prolia/Xgeva) 11,280 $18 $40
Infliximab infusion (Remicade)
An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose.
8,480 $26 $115
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
709 $97 $218
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
577 $110 $322
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
460 $12 $50
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
331 $1 $11
Zoledronic acid injection, 1 mg
An injection of zoledronic acid administered at a dose of 1 mg.
245 $6 $113
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
159 $68 $141
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
144 $23 $72
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
85 $56 $156
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
48 $50 $170
Joint fluid aspiration or injection, small joint
Removal of fluid from a small joint or injection of medication into a small joint.
28 $40 $103
Injection, methylprednisolone acetate, 40 mg 21 $6 $20
Methylprednisolone acetate injection, 20 mg
A 20 mg injection of methylprednisolone acetate, a corticosteroid medication. This code specifies the drug and dosage administered.
20 $4 $15
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
17 $130 $256
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
12 $32 $40
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
44.8% high complexity
54.4% medium
0.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$10,537
Total received (2018-2024)
Avg $1,505/year across 7 years
Top 29% in PA for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
55
Companies
559
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,205 (96.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$332 (3.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,092
2023
$1,839
2022
$1,551
2021
$1,180
2020
$846
2019
$1,489
2018
$1,541

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$315
Janssen Biotech, Inc.
$184
AstraZeneca Pharmaceuticals LP
$182
Amgen Inc.
$171
Fresenius Kabi USA, LLC
$145
Genentech USA, Inc.
$138
Lilly USA, LLC
$116
Novartis Pharmaceuticals Corporation
$112
UCB, Inc.
$110
ANI Pharmaceuticals, Inc.
$87
Alexion Pharmaceuticals, Inc.
$68
Organon Llc
$60
Sandoz Inc.
$60
Radius Health, Inc.
$55
GENZYME CORPORATION
$49
Actelion Pharmaceuticals US, Inc.
$34
E.R. Squibb & Sons, L.L.C.
$27
PFIZER INC.
$27
GlaxoSmithKline, LLC.
$23
Boehringer Ingelheim Pharmaceuticals, Inc.
$20
Kyowa Kirin, Inc.
$20
SCILEX PHARMACEUTICALS INC.
$20
Mallinckrodt Hospital Products Inc.
$18
Fidia Pharma USA Inc.
$18
Kiniksa Pharmaceuticals International, plc
$17
DePuy Synthes Sales Inc.
$15
Top 3 companies account for 32.5% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$1,661
Janssen Biotech, Inc.
$771
ABBVIE INC.
$753
UCB, Inc.
$751
Novartis Pharmaceuticals Corporation
$746
Genentech USA, Inc.
$558
AstraZeneca Pharmaceuticals LP
$518
PFIZER INC.
$483
Boehringer Ingelheim Pharmaceuticals, Inc.
$323
Lilly USA, LLC
$312
Radius Health, Inc.
$249
GlaxoSmithKline, LLC.
$219
Alexion Pharmaceuticals, Inc.
$215
AbbVie, Inc.
$205
ANI Pharmaceuticals, Inc.
$202
GENZYME CORPORATION
$192
AbbVie Inc.
$187
Fresenius Kabi USA, LLC
$170
E.R. Squibb & Sons, L.L.C.
$148
Celgene Corporation
$138
Actelion Pharmaceuticals US, Inc.
$123
Mallinckrodt Enterprises LLC
$118
Exeltis, USA Inc.
$117
Mallinckrodt Hospital Products Inc.
$113
DePuy Synthes Sales Inc.
$113
Sandoz Inc.
$109
Horizon Therapeutics plc
$92
IBSA Pharma Inc.
$80
Antares Pharma, Inc.
$64
Hikma Pharmaceuticals USA
$63
Bioventus LLC
$63
Organon Llc
$60
Sobi, Inc
$58
Flexion Therapeutics, Inc.
$52
Mallinckrodt LLC
$51
Merck Sharp & Dohme Corporation
$40
SOBI, INC
$38
Aurinia Pharma U.S., Inc.
$38
Kiniksa Pharmaceuticals, Ltd.
$36
SANOFI-AVENTIS U.S. LLC
$31
Takeda Pharmaceuticals U.S.A., Inc.
$29
Ferring Pharmaceuticals Inc.
$25
Horizon Pharma plc
$24
Kyowa Kirin, Inc.
$20
SCILEX PHARMACEUTICALS INC.
$20
Sebela Pharmaceuticals Inc.
$18
Fidia Pharma USA Inc.
$18
Cumberland Pharmaceuticals, Inc.
$18
Kiniksa Pharmaceuticals International, plc
$17
Ironwood Pharmaceuticals, Inc
$17
MEDAC PHARMA, INC.
$15
MEDEXUS PHARMA, INC.
$14
Ultragenyx Pharmaceutical Inc.
$14
Celltrion USA Inc.
$14
Mission Pharmacal Company
$12
Top 3 companies account for 30.2% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Actemra · Aquoral · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · Crysvita · Cryvista · DUZALLO · Durolane · EUFLEXXA · EVENITY · Enbrel · FORTEO · HADLIMA · HUMIRA · HYMOVIS · HYRIMOZ · Humira · IDACIO · ILARIS · INFLECTRA · KEVZARA · KINERET · KRYSTEXXA · Kineret · LUMIZYME · LUPKYNIS · LYRICA · Licart · MONOVISC · Mitigare · OFEV · OPSUMIT · ORENCIA · Otezla · Otrexup · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REDITREX · REMICADE · RENFLEXIS · RIDAURA · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · SPEVIGO · STELARA · STRENSIQ · SYNVISC-ONE · Strensiq · TALTZ · TAVNEOS · TREMFYA · Tavneos · Tirosint · Tyenne · Tymlos · UPTRAVI · Uloric · XELJANZ · YUFLYMA · ZTLido · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a rheumatology specialist in Bryn Mawr?
Compare rheumatologists in the Bryn Mawr area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
178
Per 100K population
30.9
County median income
$88,576
Nearest hospital
BRYN MAWR HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Flagg is a mixed practice specialist, with above-average Medicare volume (top 13% in PA), with low-engagement industry engagement, with 21 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Flagg experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Flagg performed 48,400 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Flagg receive payments from pharmaceutical companies?
Yes. Dr. Flagg received a total of $10,537 from 55 companies across 559 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Flagg's costs compare to other rheumatologists in Bryn Mawr?
Dr. Flagg's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Flagg) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →